MTOR and neoplasm: Several studies indicate that activation and dysregulation of the serine/threonine kinase mammalian target of rapamycin (mTOR) are associated with tumorigenesis but also processes like tumor growth, metastasis, and drug resistance in various tumor entities (Popova and Jücker 2021).